100
Participants
Start Date
July 19, 2023
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Asciminib
There is no treatment allocation. Asciminib will be prescribed by the physician as per locally approved label. No drug will be dispensed from Novartis
RECRUITING
Novartis Investigative Site, Gyeonggi-do
RECRUITING
Novartis Investigative Site, Uijeongbu-si
RECRUITING
Novartis Investigative Site, Wŏnju
RECRUITING
Novartis Investigative Site, Taegu
RECRUITING
Novartis Investigative Site, Jeollanam
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Incheon
RECRUITING
Novartis Investigative Site, Pusan
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY